Amechi Idumuebor (AGENDAWATCHDOG) – The authors of a momentous study that claimed that hydroxychloroquine raised the risks of death for coronavirus patients treated with the controversial malaria drug have retracted their research.
The retraction was published in the Lancet on Thursday, and comes just two days after the medical journal posted an ‘expression of concern.’
Along with the publication, more than 120 prominent scientists raised questions about the data used in the study, which was sourced from a database run by a private company, Surgisphere.
On the heels of that research’s May publication, international trials of the drug were halted – but the World Health Organization (WHO) announced Wednesday it would restart the hydroxychloroquine arm of its international SOLIDARITY trial.
And President Donald Trump himself continued to take the drug he dubbed a ‘game-changer’ in the hopes it would prevent infection.
The research, led by Dr Mandeep Mehra of Harvard Medical School, Dr Amit Patel of the University of Utah and Dr Frank Ruschitzka of the University Hospital Zurich, has been under outside review.
But Surgisphere refused to transfer its data to the auditors, citing patient privacy. As a result, the review was cut short and the study was retracted.
‘We can no longer vouch for the veracity of the primary data sources,’ the authors wrote to The Lancet in their retraction.